Tilray CEO Brendan Kennedy on hashish industry
CNBC’s “Energy Lunch” crew talks with Tilray CEO Brendan Kennedy about the expansion of the firm, the acquisition of Manitoba, and where the marketplace for hemp and CBD is headed….
Cronos deal presents Altria a world cannabis platform, says analyst
CNBC’s “Vitality Lunch” workforce discusses Altria’s investment in cannabis firm Cronos with Christopher Growe, an analyst at Stifel.
Cryptocurrency, cannabis and eco-aware investing: What’s forward in 2020
Tom Lydon, CEO of ETF Trends, and Carve Colas, co-founder of DataTrek Analysis, talk 2020 prospects for bitcoin, cannabis and ESG with CNBC’s Bob Pisani. They’re finally right here. Trade-traded…
Altria Neighborhood invests $1.8 billion in cannabis company Cronos Neighborhood
CNBC’s Aditi Roy discusses cigarette wide Altria Neighborhood’s $1.8 billion investment in cannabis company Cronos Neighborhood.
Fmr. FDA Commissioner Scott Gottlieb on cannabis and e-cigarette
Frail FDA Commissioner Scott Gottlieb sits down with ‘Power Lunch’ to focus on referring to the realm of marijuana entering the long-established society, e-cigarette gross sales and the measles outbreak…
2020 is the true year to put money into cannabis corporations: Entourage Execute Capital CEO
CNBC’s “Vitality Lunch” team discusses how cannabis stocks fared in 2019 and what traders must glance for in 2020 with Matt Hawkins of Entourage Execute Capital. Marijuana, gold, oil, rising…
Veil Boost CEO on constructing the U.S. pipeline for cannabis-infused drinks
Veil Boost is expanding its U.S. beverage network. CEO David Klein joins ‘Energy Lunch’ to discuss the firm’s pursuit of growth, its new partnership and how constructing out the pipeline…
Cannabis users, investors would possibly well per chance face US ban at Canada border
CNBC’s Aditi Roy reports that Canadian who’s fascinated by the marijuana industry or is caught utilizing it’ll also face a ban from the U.S. at the united statesCanada border.
Total sales solid despite vaping crisis: Cannabis investor
Matt Hawkins of Entourage Enact Capital joins CNBC’s “Energy Lunch” group to focus on how the vaping epidemic is impacting hashish investing.
Cannabis infusion has scientific complexities, says Tilray CEO
CNBC’s “Energy Lunch” is joined by Brendan Kennedy, president and CEO of Tilray, to talk in regards to the firm’s recent Anheuser-Busch partnership. » Subscribe to CNBC: About CNBC: From…